미용 의료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 시술 유형별(침습적 시술, 비침습적 시술), 지역별, 경쟁별(2020-2030년)

The Global Aesthetic Medicine Market was valued at USD 133.25 billion in 2024 and is projected to reach USD 267.14 billion by 2030, growing at a CAGR of 12.25%. This market is experiencing significant expansion driven by demographic changes, advancements in technology, evolving cultural perceptions of beauty, and increasing consumer spending on personal care. The industry encompasses a wide array of invasive and non-invasive treatments designed to enhance appearance, rejuvenate the skin, and reduce age-related imperfections. Key offerings include neuromodulators like Botox(R) and Dysport(R), dermal fillers, laser procedures, non-surgical body contouring, and hair restoration. These treatments are now being adopted as part of ongoing self-care routines rather than occasional cosmetic interventions. The aesthetic devices segment is also gaining traction, with new technologies such as ultrasound-guided contouring and fractional lasers offering improved outcomes. A shift toward preventive care is redefining aesthetic medicine from a luxury choice to a recurring investment in wellness and self-image.

Key Market Drivers

Growing Demand for Minimally Invasive Procedures

The rising demand for minimally invasive aesthetic procedures is a key driver of the global aesthetic medicine market. In 2023 alone, about 25.4 million minimally invasive cosmetic procedures were performed globally, indicating a shift in consumer preference toward treatments with minimal downtime and reduced risk. These procedures-such as Botox injections, dermal fillers, laser resurfacing, and microneedling-offer aesthetic improvements with greater convenience and less recovery time than traditional surgeries. Products like Botox, Dysport, Xeomin, and Jeuveau continue to lead the market, with nearly 9.5 million procedures recorded, marking a 9% year-over-year increase. This trend is particularly popular among working professionals and younger individuals who favor discreet, time-efficient treatments. The market is also expanding demographically, with more men and first-time users opting for non-surgical enhancements. As a result, clinics are seeing increased patient traffic and retention, making these offerings a central component of aesthetic service portfolios.

Key Market Challenges

Safety Concerns

Despite their popularity, aesthetic procedures-especially minimally invasive ones-are not without risks, which remain a major concern for both consumers and practitioners. Adverse events such as infections, allergic reactions, scarring, and tissue necrosis can deter potential patients. Negative media coverage of unsuccessful treatments further fuels public apprehension and can damage industry reputation. These safety issues also invite greater regulatory scrutiny, which can complicate clinical operations and restrict access to certain procedures. Practitioners must also navigate the legal risks of malpractice claims, which can drive up insurance costs and lead to reduced service offerings. Educating patients thoroughly about the potential risks and setting realistic expectations are essential but time-intensive tasks that may slow the decision-making process, thereby affecting market momentum.

Key Market Trends

Customization and Personalization

A major trend shaping the aesthetic medicine market is the growing emphasis on personalized and customized treatments. Patients are increasingly seeking procedures tailored to their unique facial structures, aesthetic goals, and skin types-whether for wrinkle reduction, contouring, or pigmentation correction. Personalized approaches lead to higher satisfaction, improved outcomes, and stronger practitioner-patient relationships, fostering loyalty and repeat visits. Technological advancements such as AI-driven diagnostics, 3D imaging, and digital simulation tools allow providers to design highly individualized treatment plans. This inclusive approach accommodates diverse patient demographics across ethnicities, genders, and age groups. Additionally, personalized aesthetic regimens often involve multi-step, combination treatments that deliver comprehensive results, further enhancing the appeal of custom solutions in today's beauty market.

Key Market Players

• Evolus, Inc.
• Cynosure LLC.
• Revance Therapeutics, Inc.
• Galderma S.A.
• Alma Lasers Inc.
• AbbVie Inc.
• Solta Medical Inc.
• Lumenis Inc.
• Syneron Inc.
• Bausch Health Companies, Inc.

Report Scope:

In this report, the Global Aesthetic Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Aesthetic Medicine Market, By Procedure Type:

• Invasive procedures
• Non-invasive procedure

Aesthetic Medicine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Aesthetic Medicine Market.

Available Customizations:

Global Aesthetic Medicine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Aesthetic Medicine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Procedure Type (Invasive procedures, Non-invasive procedure)
    • 5.2.1.1. By Invasive procedures (Breast Augmentation, Liposuction, Nose Reshaping, Eyelid Surgery, Tummy Tuck, Others)
    • 5.2.1.2. By Non-invasive procedures (Botox Injections, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, Microdermabrasion, Others)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America Aesthetic Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Procedure Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Aesthetic Medicine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Procedure Type
  • 6.3.2. Canada Aesthetic Medicine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Procedure Type
  • 6.3.3. Mexico Aesthetic Medicine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Procedure Type

7. Europe Aesthetic Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Procedure Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Aesthetic Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Procedure Type
  • 7.3.2. United Kingdom Aesthetic Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Procedure Type
  • 7.3.3. Italy Aesthetic Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Procedure Type
  • 7.3.4. France Aesthetic Medicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Procedure Type
  • 7.3.5. Spain Aesthetic Medicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Procedure Type

8. Asia-Pacific Aesthetic Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Procedure Type
  • 8.2.2. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Aesthetic Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Procedure Type
  • 8.3.2. India Aesthetic Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Procedure Type
  • 8.3.3. Japan Aesthetic Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Procedure Type
  • 8.3.4. South Korea Aesthetic Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Procedure Type
  • 8.3.5. Australia Aesthetic Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Procedure Type

9. South America Aesthetic Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Procedure Type
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Aesthetic Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Procedure Type
  • 9.3.2. Argentina Aesthetic Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Procedure Type
  • 9.3.3. Colombia Aesthetic Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Procedure Type

10. Middle East and Africa Aesthetic Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Procedure Type
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Aesthetic Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Procedure Type
  • 10.3.2. Saudi Arabia Aesthetic Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Procedure Type
  • 10.3.3. UAE Aesthetic Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Procedure Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Aesthetic Medicine Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Evolus, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Cynosure LLC.
• 14.3. Revance Therapeutics, Inc.
• 14.4. Galderma S.A.
• 14.5. Alma Lasers Inc.
• 14.6. AbbVie Inc.
• 14.7. Solta Medical Inc.
• 14.8. Lumenis Inc.
• 14.9. Syneron Inc.
• 14.10.Bausch Health Companies, Inc..

15. Strategic Recommendations

16. About Us & Disclaimer